IHE
iShares U.S. Pharmaceuticals ETF
Price Chart
Latest Quote
$103.35
+0.54 (+0.53%)
Current Price
| Previous Close | $102.81 |
| Open | $102.58 |
| Day High | $103.63 |
| Day Low | $102.57 |
| Volume | 249,867 |
Fund Information
| Quarterly Dividend / Yield | N/A / 1.43% |
| Net Assets | $1.63B |
| Expense Ratio | 0.37% |
| Category | Health |
| Fund Family | iShares |
| Net Asset Value | $102.82 |
| Premium/Discount | 0.52% |
| Quarterly Dividend Yield | 1.43% |
| P/E Ratio | 27.06 |
| Exchange | PCX |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $100.63 |
| SMA50 | $102.33 |
| SMA200 | $94.05 |
| RSI | 61.20 |
| ATR | 2.0257 |
| Rel Volume | 0.85 |
Performance History
| Week | -0.12% |
| Month | +0.16% |
| Quarter | +0.13% |
| 6 Months | +21.23% |
| YTD | +22.88% |
| Year | +40.08% |
| 3 Years | +86.24% |
| 5 Years | +82.50% |
| 10 Years | +161.25% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $103.35 | 250,000 |
| 2026-10-26 | $102.81 | 121,900 |
| 2026-10-23 | $102.51 | 126,000 |
| 2026-10-22 | $104.78 | 316,300 |
| 2026-10-21 | $102.78 | 279,200 |
| 2026-10-20 | $103.47 | 152,300 |
| 2026-10-19 | $100.58 | 188,700 |
| 2026-10-16 | $101.06 | 458,800 |
| 2026-10-15 | $101.12 | 165,200 |
| 2026-10-14 | $99.49 | 432,200 |
| 2026-10-13 | $97.36 | 117,200 |
| 2026-10-12 | $100.19 | 161,500 |
| 2026-10-09 | $100.09 | 342,400 |
| 2026-10-08 | $98.86 | 331,400 |
| 2026-10-07 | $99.39 | 384,200 |
| 2026-10-06 | $98.34 | 327,900 |
| 2026-10-05 | $98.22 | 577,300 |
| 2026-10-02 | $98.65 | 663,700 |
| 2026-10-01 | $99.00 | 235,000 |
| 2026-09-30 | $100.52 | 238,200 |
| 2026-09-29 | $102.26 | 96,500 |
| 2026-09-28 | $103.19 | 69,700 |
About iShares U.S. Pharmaceuticals ETF
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.
đ° Latest News
No news articles available at the moment. Check back later for updates on IHE.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.